Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Coagulation Disorders and of Enoxaparin's Anti-Xa Activity, When Used for Thromboprophylaxis, in Severe Nephrotic Syndrome.

NCT04558892 is registered in ClinicalTrials.gov with Military Institute od Medicine National Research Institute as lead sponsor.

NCT NCT04558892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Coagulation Disorders and of Enoxaparin's Anti-Xa Activity, When Used for Thromboprophylaxis, in Severe Nephrotic Syndrome.
Lead sponsor
Military Institute od Medicine National Research Institute
Phase
Phase 2/3
Overall status
Terminated
Start date
October 1, 2015
Completion date
November 30, 2018
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome